Education
About Us
Working with TipRanks
Follow Us
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)
ASX:RMD
RMD Stock Chart & Stats
AU$38.50
AU$0.22(0.59%)
At close: 4:00 PM EST
AU$38.50
AU$0.22(0.59%)
Day’s Range― - ―
52-Week RangeAU$32.04 - AU$45.25
Previous CloseN/A
Volume1.29M
Average Volume (3M)1.08M
Market Cap
AU$56.31B
Enterprise ValueAU$3.44B
Total Cash (Recent Filing)AU$1.38B
Total Debt (Recent Filing)AU$846.35M
Price to Earnings (P/E)25.3
Beta0.90
Next Earnings
Jan 29, 2026EPS Estimate
0.41Next Dividend Ex-DateN/A
Dividend Yield0.95%
Share Statistics
EPS (TTM)0.38
Shares Outstanding1,459,663,000
10 Day Avg. Volume805,465
30 Day Avg. Volume1,076,544
Financial Highlights & Ratios
PEG Ratio0.75
Price to Book (P/B)6.36
Price to Sales (P/S)7.38
P/FCF Ratio23.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$48.36Price Target Upside25.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market OpportunitiesThere is no clarity on Philips’ return to the US market, which may benefit RMD in the short term.
Promotional ActivitiesRMD expects its sponsors to ramp up promotional activity in 2H CY25, which could positively impact the business.
Valuation And GrowthUpgrade to Buy on reasonable valuation, strong EPS growth, FCF, and no debt by FY end.
Bears Say
Healthcare CapacityHealthcare systems’ capacity constraints will likely keep a lid on new patients growth.
Market ReactionRMD’s share price has historically reacted negatively to news flow on GLP-1s.
Product PerformanceThe growth in RMD US app downloads is tracking below the US Devices sales growth consensus.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh News
RMD FAQ
What was Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price range in the past 12 months?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh lowest share price was AU$32.04 and its highest was AU$45.25 in the past 12 months.
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap is AU$56.31B.
When is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s upcoming earnings report date?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s upcoming earnings report date is Jan 29, 2026 which is in 15 days.
How were Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s earnings last quarter?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh released its earnings results on Oct 30, 2025. The company reported AU$0.382 earnings per share for the quarter, beating the consensus estimate of AU$0.377 by AU$0.004.
Is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh overvalued?
According to Wall Street analysts Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price is currently Undervalued.
Does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pay dividends?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pays a Quarterly dividend of AU$0.092 which represents an annual dividend yield of 0.95%. See more information on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh dividends here
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate is 0.41.
How many shares outstanding does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh have?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has 1,459,663,000 shares outstanding.
What happened to Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price movement after its last earnings report?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh reported an EPS of AU$0.382 in its last earnings report, beating expectations of AU$0.377. Following the earnings report the stock price went up 1.649%.
Which hedge fund is a major shareholder of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh?
Currently, no hedge funds are holding shares in AU:RMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$48.36 (25.61% Upside)
AU$48.36 (25.61% Upside)
Blogger Sentiment
Bullish
AU:RMD Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.26%
12-Months-Change
Fundamentals
Return on Equity
26.73%
Trailing 12-Months
Asset Growth
21.21%
Trailing 12-Months
Company Description
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Earnings & Revenues
RMD Revenue Breakdown
88.21% Sleep and Respiratory Care
11.79% Software as a Service
RMD Stock 12 Month Forecast
Average Price Target
AU$48.36
▲(25.61% Upside)
Technical Analysis
Sigma Healthcare Ltd
―
Cochlear
―
Pro Medicus Limited
―
Ramsay Health Care
―
Sonic Healthcare Limited
―
Options Prices
Currently, No data available
---